RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CANDIDO R
Collezione AOU Alessandria

Items : 11

Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review. in Journal of endocrinological investigation / J Endocrinol Invest. 2026 Apr;49(4):709-723. doi: 10.1007/s40618-025-02764-5. Epub 2025 Dec 3.

2026
AOU Alessandria

Felicetti F; Mazzilli R; Gori S; Gallo M; Cortellini A; D'Oronzo S; Gristina V; Argentiero A; Candido R; Del Re M; Fogli S; Franchina T; Giuffrida D; Marino G; Monami M; Montagnani M; Morviducci L; Natalicchio A; Ragni A; Renzelli V; Sciacca L; Tuveri E; Giorgino F; Verzé M; Zatelli MC; Arvat E; Perrone F; Stracci F; Aimaretti G; et alii...

Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies. in Journal of endocrinological investigation / J Endocrinol Invest. 2025 Aug;48(8):1717-1738. doi: 10.1007/s40618-025-02586-5. Epub 2025 Apr 23.

2025
AOU Alessandria

Gallo M; Lasagna A; Renzelli V; Morviducci L; Cortellini A; Monami M; Marino G; Gori S; Verzé M; Ragni A; Tuveri E; Sciacca L; D'Oronzo S; Giuffrida D; Natalicchio A; Giorgino F; Marrano N; Zatelli MC; Montagnani M; Felicetti F; Mazzilli R; Fogli S; Franchina T; Argentiero A; Candido R; Perrone F; Aimaretti G; Avogaro A; Silvestris N; et alii...

Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group. in Cancer treatment reviews / Cancer Treat Rev. 2024 May;126:102734. doi: 10.1016/j.ctrv.2024.102734. Epub 2024 Apr 3.

2024
AOU Alessandria

Zatelli MC; Faggiano A; Argentiero A; Danesi R; D'Oronzo S; Fogli S; Franchina T; Giorgino F; Marrano N; Giuffrida D; Gori S; Marino G; Mazzilli R; Monami M; Montagnani M; Morviducci L; Natalicchio A; Ragni A; Renzelli V; Russo A; Sciacca L; Tuveri E; Aimaretti G; Avogaro A; Candido R; Di Maio M; Silvestris N; Gallo M;

Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view. in Journal of endocrinological investigation / J Endocrinol Invest. 2024 Dec;47(12):2915-2928. doi: 10.1007/s40618-024-02417-z. Epub 2024 Jun 27.

2024
AOU Alessandria
AOU Città della Salute di Torino

Silvestris N; Aimaretti G; Perrone F; Candido R; Di Maio M; Tuveri E; Cortellini A; Sciacca L; Russo A; Morviducci L; Renzelli V; Monami M; Mazzilli R; Marino G; Ragni A; Gori S; Giuffrida D; Franchina T; Fogli S; D'Oronzo S; Argentiero A; Del Re M; Faggiano A; Zatelli MC; Gallo M; Avogaro A; Montagnani M; Marrano N; Natalicchio A; et alii...

Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1846-1853. doi: 10.1016/j.numecd.2024.03.023. Epub 2024 Ma

2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano

Rossi MC; Napoli R; Larosa M; Nicolucci A; Candido R;

Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2294-2305. doi: 10.1016/j.numecd.2023.07.025. Epub 2023 J

2023
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano

Napoli R; Candido R; Larosa M; Nicolucci A; Rossi MC;

Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study. in Diabetes therapy : research, treatment and education of diabetes and related disorders / Diabetes Ther. 2023 Jan;14(1):77-92. doi: 10.1007/s13300-022-01328-7. Epub 2022 Nov 14.

2023
AOU Alessandria

Candido R; Modugno M; Larosa M; Rossi MC; Nicolucci A; Gabellieri E;

Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2023 Feb;25(2):444-453. doi: 10.1111/dom.14888. Epub 2022 Oct 24.

2023
AOU Alessandria

Targher G; Candido R; Pintaudi B; Giaccari A; Gallo M; Mannucci E; Monami M;

Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):529-536. doi: 10.1016/j.numecd.2021.12.006. Epub 2021 Dec

2022
AOU Alessandria

Mannucci E; Giaccari A; Gallo M; Targher G; Pintaudi B; Candido R; Monami M;

Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Jun;32(6):1353-1360. doi: 10.1016/j.numecd.2022.03.007. Epub 2022 Ma

2022
AOU Alessandria

Mannucci E; Targher G; Nreu B; Pintaudi B; Candido R; Giaccari A; Gallo M; Monami M;

All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Feb;32(2):511-514. doi: 10.1016/j.numecd.2021.10.010. Epub 2021 Nov

2022
AOU Alessandria

Mannucci E; Gallo M; Pintaudi B; Targher G; Candido R; Giaccari A; Monami M;